RCEL Investors Have Opportunity to Join AVITA Medical, Inc. Fraud Investigation with the Schall Law Firm

Core Viewpoint - The Schall Law Firm is investigating AVITA Medical, Inc. for potential violations of securities laws, focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Company Summary - AVITA Medical, Inc. (NASDAQ: RCEL) reported a significant backlog in unpaid provider claims for RECELL procedures, which impacted demand in the first half of 2025 [2]. - The backlog was attributed to failures by contractors from the Centers for Medicare & Medicaid Services, leading to uncertainty among providers regarding payment expectations and timelines [2]. Legal Context - The investigation by the Schall Law Firm aims to determine if AVITA Medical misled investors regarding its financial health and operational challenges [1][2]. - Shareholders who have suffered losses are encouraged to participate in the investigation [2].